80
Views
0
CrossRef citations to date
0
Altmetric
Assisted reproduction

Antral follicle count measured at down-regulation as predictor of ovarian response and cumulative live birth: single center analysis including 2731 long agonist IVF cycles

, , , , , & show all
Pages 1079-1086 | Received 15 May 2022, Accepted 28 Nov 2022, Published online: 07 Dec 2022

References list

  • Bosch E, Broer S, Griesinger G, et al. ESHRE guideline: ovarian stimulation for IVF/ICSI†. Hum Reprod Open. 2020;2020:1–13.
  • Lambalk CB, Banga FR, Huirne JA, et al. GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type. Hum Reprod Update. 2017;23(5):560–579.
  • Toftager M, Bogstad J, Løssl K, et al. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols. Hum Reprod. 2017;32(3):556–567.
  • Niederberger C, Pellicer A, Cohen J, et al. Forty years of IVF. Fertil Steril. 2018;110(2):185–324.e5.
  • Maheshwari A, McLernon D, Bhattacharya S. Cumulative live birth rate: time for a consensus? Hum. Reprod. 2015;30(12):2703–2707
  • Polyzos NP, Drakopoulos P, Parra J, et al. Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection: a multicenter multinational analysis including ∼15,000 women. Fertil Steril. 2018;110(4):661–670.e1.
  • Law YJ, Zhang N, Venetis CA, et al. The number of oocytes associated with maximum cumulative live birth rates per aspiration depends on female age: a population study of 221 221 treatment cycles. Hum Reprod. 2019;34(9):1778–1787.
  • Balachandren N, Salman M, Diu NL, et al. Ovarian reserve as a predictor of cumulative live birth. Eur J Obstet Gynecol Reprod Biol. 2020;252:273–277.
  • Arce JC, La Marca A, Mirner Klein B, et al. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients. Fertil Steril. 2013;99(6):1644–1653.
  • Li HWR, Lee VCY, Lau EYL, et al. Role of baseline antral follicle count and anti-Mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: a retrospective cohort analysis. PLoS One. 2013;8(4):e61095.
  • Hamdine O, Eijkemans MJC, Lentjes EGW, et al. Antimüllerian hormone: prediction of cumulative live birth in gonadotropin-releasing hormone antagonist treatment for in vitro fertilization. Fertil Steril. 2015;104(4):891–898.e2.
  • Alson SSE, Bungum LJ, Giwercman A, et al. Anti-müllerian hormone levels are associated with live birth rates in ART, but the predictive ability of anti-müllerian hormone is modest. Eur J Obstet Gynecol Reprod Biol. 2018;225:199–204.
  • Broekmans FJM, De Ziegler D, Howles CM, et al. The antral follicle count: practical recommendations for better standardization. Fertil Steril. 2010;94(3):1044–1051.
  • Sharara FI, Lim J, McClamrock HD. The effect of pituitary desensitization on ovarian volume measurements prior to in-vitro fertilization. Hum Reprod. 1999;14(1):183–185.
  • Ng EHY, Chan CCW, Tang OS, et al. Effect of pituitary downregulation on antral follicle count, ovarian volume and stromal blood flow measured by three-dimensional ultrasound with power doppler prior to ovarian stimulation. Hum Reprod. 2004;19(12):2811–2815.
  • Jayaprakasan K, Campbell BK, Hopkisson JF, et al. Effect of pituitary desensitization on the early growing follicular cohort estimated using anti-Mullerian hormone. Hum Reprod. 2008;23(11):2577–2583.
  • Jayaprakasan K, Hopkisson JF, Campbell BK, et al. Quantification of the effect of pituitary down-regulation on 3D ultrasound predictors of ovarian response. Hum Reprod. 2008;23(7):1538–1544.
  • Khairy M, Clough A, El-Toukhy T, et al. Antral follicle count at down-regulation and prediction of poor ovarian response. Reprod Biomed Online. 2008;17(4):508–514.
  • Tran ND, Aghajanova L, Kao CN, et al. Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation. Fertil Steril. 2016;105(3):690–696.
  • Cardenas Armas DF, Peñarrubia J, Goday A, et al. Frozen-thawed blastocyst transfer in natural cycle increase implantation rates compared artificial cycle. Gynecol Endocrinol. 2019;35(10):873–877.
  • Golan A, Ron-El R, Herman A, et al. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv. 1989;44(6):430–440.
  • Duffy JMN, Bhattacharya S, Bofill M, et al. Standardizing definitions and reporting guidelines for the infertility core outcome set: an international consensus development study. Fertil Steril. 2021;115(1):201–212.
  • Zegers-Hochschild F, Adamson GD, Dyer S, et al. The international glossary on infertility and fertility care, 2017. Hum Reprod. 2017;32(9):1786–1801.
  • Zegers-Hochschild F, Adamson GD, Dyer S, et al. The international glossary on infertility and fertility care, 2017. Fertil Steril. 2017;108(3):393–406.
  • Martínez F, Mancini F, Solé M, et al. Antagonist rescue of agonist IVF cycle at risk of OHSS: a case series. Gynecol Endocrinol. 2014;30(2):145–148.
  • Martínez F, Rodríguez DB, Buxaderas R, et al. GnRH antagonist rescue of a long-protocol IVF cycle and GnRH agonist trigger to avoid ovarian hyperstimulation syndrome: three case reports. Fertil Steril. 2011;95(7):2432.e17–2432.e19.
  • Hill MJ, Chason RJ, Payson MD, et al. GnRH antagonist rescue in high responders at risk for OHSS results in excellent assisted reproduction outcomes. Reprod Biomed Online. 2012;25(3):284–291.
  • Goyal A, Kuchana M, Ayyagari KPR. Machine learning predicts live-birth occurrence before in-vitro fertilization treatment. Sci Rep. 2020;10(1):20925.
  • Hassan MR, Al-Insaif S, Hossain MI, et al. A machine learning approach for prediction of pregnancy outcome following IVF treatment. Neural Comput & Applic. 2020;32(7):2283–2297.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.